Medivation Announces Fourth Quarter and Year-End 2012 Financial Results Teleconference on February 28, 2013

Medivation Announces Fourth Quarter and Year-End 2012 Financial Results 
Teleconference on February 28, 2013 
SAN FRANCISCO, CA -- (Marketwire) -- 02/14/13 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will host a live
teleconference with management to discuss fourth quarter and year-end
2012 financial results and provide a general business update on
February 28, 2013 at 4:30 p.m. Eastern Time. A press release for the
fourth quarter and year-ended 2012 will be released after markets
close on February 28, 2013. 
Interested parties may listen to the live teleconference by calling
877-303-2523 from the U.S. or +1-253-237-1755 internationally.
Individuals may access the live audio webcast by visiting:
http://investors.medivation.com/events.cfm. A replay of the webcast
will be available on the Company's website for 30 days following the
live event. 
About Medivation 
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com. 
Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101 
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900